Modern CTO How Robots are Becoming Surgeons with David Fischel, CEO at Stereotaxis
Sep 1, 2025
In this discussion, David Fischel, CEO of Stereotaxis, reveals how robots are revolutionizing surgeries with unprecedented precision. He explains the use of magnetic fields to control catheters during procedures, enhancing minimally invasive techniques. David also delves into the future of robotic systems, emphasizing their potential for greater accessibility in endovascular surgeries. The conversation highlights the collaboration between humans and machines, showcasing innovative advancements and the role of AI in improving patient safety and outcomes.
AI Snips
Chapters
Transcript
Episode notes
Name Reflects Original Brain-Targeting Idea
- Stereotaxis name comes from an early idea to place radioactive seeds precisely in brain tumors using stereotactic techniques.
- The company evolved into robotic endovascular catheter navigation because magnetic control fit those procedures better.
Robotics Varies By Surgical Domain
- Robotic surgery spans laparoscopic, orthopedic, and endovascular domains with different leading systems and adoption patterns.
- Intuitive Surgical dominates laparoscopic robots while Stereotaxis focuses on pioneering endovascular robotics.
Endovascular Is A Minimally Invasive Highway
- Endovascular surgery uses blood vessels as highways to reach organs via tiny catheters for treatments like stents or clot aspiration.
- Stereotaxis's robotic focus has concentrated mainly on treating cardiac rhythm disorders by precisely positioning catheters in the heart.